AI-Rad Companion (Cardiovascular) vs AVIEW

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Siemens Healthineers
VS
by Coreline Soft Co.

AI Verdict

These two tools are adjacent competitors, primarily overlapping in their capability for coronary artery calcium scoring from CT images. AI-Rad Companion (Cardiovascular) offers a dedicated focus on comprehensive cardiovascular analysis, including detailed aorta and heart measurements. In contrast, AVIEW provides a broader platform, integrating coronary artery calcification analysis with extensive solutions for lung cancer and COPD detection and monitoring.

Choose AI-Rad Companion (Cardiovascular) if…

Choose AI-Rad Companion (Cardiovascular) if your primary need is a highly specialized, in-depth analysis of cardiovascular structures from CT images. This tool excels in precise quantification of coronary calcium volume, detailed segmentation and measurement of the thoracic aorta, and comprehensive heart volume assessment, providing standardized reports for cardiology-focused workflows.

View AI-Rad Companion (Cardiovascular) →

Choose AVIEW if…

Choose AVIEW if you require a versatile AI platform for multi-organ screening and diagnosis, particularly when evaluating both pulmonary and cardiovascular conditions from a single CT scan. Its strengths lie in comprehensive lung nodule detection, emphysema quantification, and detailed coronary artery calcium scoring, alongside robust follow-up capabilities for longitudinal patient management.

View AVIEW →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-Rad Companion (Cardiovascular) AVIEW
Pricing Contact vendor for pricing Subscription; one-off payment
Deployment Cloud-based (via teamplay digital health platform) and Edge deployment Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker)
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AI-Rad Companion (Cardiovascular)

AI-Rad Companion emphasizes seamless integration into existing clinical workflows and PACS, with automatic post-processing and generation of standardized DICOM SC reports, aiming to reduce repetitive tasks for radiologists. It also offers a 'Notifier' for PACS-independent review and a 'Trial Light' for easy algorithm experience, indicating a strong focus on practical user experience.

Clinical Value

AVIEW

AVIEW offers a broader clinical scope, covering lung cancer, COPD, and coronary artery calcification from a single CT scan, in addition to ILD pattern analysis. [cite: JSON, 22, 27, 32, 35] It provides detailed quantitative analysis, including Lung-RADS and Agatston scores, and has demonstrated high sensitivity and specificity in clinical validation for nodule detection, making it a more comprehensive diagnostic aid.

Pricing & Value

AVIEW

AVIEW is more transparent about its pricing structure, explicitly stating both subscription and one-off payment models, with pricing based on the number of installations or users. [cite: JSON] In contrast, AI-Rad Companion primarily directs users to 'contact vendor for pricing,' offering less upfront clarity on potential cost structures. [cite: JSON]

Enterprise Readiness

AVIEW

Both tools are HIPAA compliant and FDA cleared, but AVIEW offers more flexible deployment options including cloud-based, hybrid, local on dedicated hardware, and locally virtualized solutions. [cite: JSON, 32, 35] This wider range of deployment choices provides greater adaptability for diverse enterprise IT infrastructures and data governance requirements.

Innovation

AVIEW

AVIEW demonstrates significant innovation through its unified AI platform (AVIEW 2.0) that integrates and automates diagnostics across pulmonary, cardiac, and airway pathologies from a single examination. This comprehensive, multi-disease approach, including features like ILD pattern analysis and Volume Doubling Time (VDT) calculation, offers a more expansive innovative solution compared to Tool A's primarily cardiovascular focus. [cite: JSON, 22, 27, 32]

Support & Docs

AI-Rad Companion (Cardiovascular)

Siemens Healthineers provides a dedicated 'Academy' with structured user guides and online training for AI-Rad Companion, covering software overviews, workflow integration, and specific modules. This indicates a robust and accessible ecosystem for user education and support. While AVIEW likely has standard documentation, explicit mentions of such comprehensive educational resources are not as prominent.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-Rad Companion (Cardiovascular) AVIEW
Product Name AI-Rad Companion (Cardiovascular) AVIEW
Company Siemens Medical Solutions U. Coreline Soft Co.
Primary AI Focus Quantitative and qualitative analysis of CT DICOM images to support physicians in evaluating cardiovascular diseases. Early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans.
Coronary Artery Calcium (CAC) Scoring Automatic recognition and quantification of coronary calcium volume from CT images. CAC scoring (Agatston, volume, mass score, risk stratification)
Lung Nodule Detection Not specified AI-powered lung nodule detection and characterization (size, volume, type, location, Lung-RADS score)
Aorta Analysis Automatic 3D overview and segmentation of the thoracic aorta. Measurement of relevant aorta diameters based on medical guidelines and detected anatomical landmarks. Threshold-based highlighting of enlarged aorta diameters. Not specified
Heart Segmentation Segmentation and volume measurement of the heart. Not specified
Reporting Format Automatic generation of standardized, reproducible, and quantitative reports (DICOM SC format). Comprehensive PDF reports.

Videos

Demos, reviews, and walkthroughs featuring AI-Rad Companion (Cardiovascular) and AVIEW.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AI-Rad Companion (Cardiovascular) primarily focuses on the heart, thoracic aorta, and coronary arteries for the evaluation of cardiovascular diseases. AVIEW, on the other hand, offers comprehensive analysis for lung cancer, COPD, and coronary artery calcification, including detailed assessment of lung nodules, emphysema, and interstitial lung disease (ILD) patterns, in addition to coronary artery calcification.
AI-Rad Companion (Cardiovascular) provides automatic recognition and quantification of coronary calcium volume from CT images. AVIEW offers a more comprehensive coronary artery calcium (CAC) scoring, which includes Agatston, volume, and mass scores, along with risk stratification.
AVIEW provides extensive features for lung pathology, such as AI-powered lung nodule detection and characterization (including size, volume, type, location, and Lung-RADS score), emphysema quantification and low attenuation area (LAA) analysis, and interstitial lung disease (ILD) pattern analysis (AVIEW Lung Texture). AI-Rad Companion (Cardiovascular) focuses exclusively on cardiovascular analysis and does not list these lung-specific pathology features.
AI-Rad Companion (Cardiovascular) automatically generates standardized, reproducible, and quantitative reports in DICOM SC format. AVIEW offers 3D visualizations and comprehensive PDF reports, in addition to DICOM Structured Reports.
AI-Rad Companion (Cardiovascular) is designed for seamless integration into existing clinical workflows and Picture Archiving and Communication Systems (PACS). AVIEW provides workflow automation and integration with PACS, Radiology Information Systems (RIS), and Clinical Information Systems (CIS).
AVIEW explicitly includes features for follow-up registration and nodule matching for serial CT scans, and can calculate nodule volume doubling time for tracking progression. AI-Rad Companion (Cardiovascular) focuses on initial analysis and reporting, with no explicit mention of specific follow-up tracking features for disease progression in its description.
AI Tool Finder
AI-powered search. Results may not be comprehensive.